This inventor holds 2 USPTO granted patents. Top assignee: Massachusetts Institute of Technology. Active years: 2016-2017.
Company Filing History:
Years Active: 2016-2017
Title: Amanda R Dilenno: Innovator in Stem Cell Research
Introduction
Amanda R Dilenno is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of stem cell research, holding 2 patents that focus on innovative methods for stem cell differentiation. Her work is particularly relevant in the context of regenerative medicine and diabetes treatment.
Latest Patents
Dilenno's latest patents include "Articles and methods for stem cell differentiation" and "Method for differentiating human embryonic stem cells into β-cells for the treatment of type I diabetes." The first patent describes articles for stem cell differentiation that utilize an oxygen permeable substrate coated with a matrix. This matrix allows for controlled cell-substrate interactions while maintaining oxygen permeability. The second patent provides methods for differentiating embryonic stem cells into insulin-producing cells, which have therapeutic applications for type I diabetes.
Career Highlights
Amanda R Dilenno is affiliated with the Massachusetts Institute of Technology, where she continues her research and development in stem cell technologies. Her innovative approaches have the potential to advance medical treatments and improve patient outcomes.
Collaborations
Dilenno has collaborated with notable colleagues, including Clark K Colton and Jeffrey R Millman, to further her research initiatives. Their combined expertise enhances the impact of their work in the field of stem cell differentiation.
Conclusion
Amanda R Dilenno is a trailblazer in stem cell research, with her patents paving the way for advancements in medical treatments. Her contributions are vital to the ongoing exploration of regenerative medicine and diabetes therapy.